Revenue

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

With its fourth major Brazilian acquisition, Evertec buys Dimensa to capture a larger share of Latin America's most dynamic financial technology market.

Collective Acquisition Corp. II, led by finance vets and military leaders, closes a $220M IPO to hunt for deals in defense tech, AI, and strategic resources.

A massive lawsuit plunged the brewer into a deep quarterly loss, overshadowing operational gains and highlighting struggles in a shifting beverage market.

A major financing deal preserves critical affordable housing in a high-cost DC area, offering a lifeline to residents and a blueprint for urban renewal.

The chemical giant's Q1 earnings fell year-over-year, but strong sequential growth and a "net upside" from global conflict fuel an optimistic 2026 outlook.

The consulting firm posted double-digit Q1 growth, fueled by its critical role in securing AI-powered products and fortifying energy infrastructure.

The new Cal Rehab clinic in Garden Grove marks the 39th joint venture for PRN and MemorialCare, expanding integrated healthcare access in Southern California.

Strata Critical Medical acquires Ohio Valley Perfusion Associates, a strategic move to consolidate the fragmented perfusion market and boost lifesaving care.

With cash burn rising, Summit Therapeutics races toward a November FDA decision on its novel cancer drug ivonescimab and a major data reveal at ASCO.

With a new $19 entry-level plan and a scalable ecosystem, MioCommerce is making a strategic play to equip service businesses from solo startups to large teams.

With a history of strong growth, Jefferson Capital's upcoming earnings are a key indicator for investors and the consumer debt market. Will it deliver?

MPS smashes Q1 revenue records, fueled by a 98% surge in its AI data segment. The company now eyes a massive $6 billion capacity expansion.

With record growth and raised guidance, the REIT leverages market trends and strategic partnerships to solidify its leadership in medical real estate.

Amid a Q2 net loss driven by rising mortgage rates and geopolitical tension, Beazer Homes accelerates share repurchases, signaling confidence in its strategy.

A new program offers local manufacturers integrated financial, strategic, and PR support at a fraction of the cost, aiming to boost a key regional industry.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

Bain-backed Archwest Capital surpasses $2.5B in funding and poaches top talent, intensifying competition in the private real estate lending market.

Following a record-breaking quarter, Enova's executives will detail their AI-powered growth engine and future outlook at the Needham investor conference.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.